HealthDay - TUESDAY, Nov. 17 (HealthDay News) — Patients who received bone
marrow stem cell transplants during coronary bypass surgery (CABG)
experienced “excellent long-term safety and survival,” say German
researchers, who also noted the first promising results for stem cell
transplantation during mitral valve repair.

Źródło: http://us.rd.yahoo.com/dailynews/rss/science/*http://news.yahoo.com/s/hsn/20091118/hl_hsn/stemcellsmayimproveheartbypassresults

Comments are closed